Isolongifolene-Loaded Chitosan Nanoparticles Synthesis And Characterization For Cancer Treatment
Keywords:
Targeted drug delivery, Nano particle, Chitosan, Nano capsulated system, LiposomesAbstract
The advancements of nanoparticle-based treatment approaches have revolutionized the cancer treatment strategy, as novel approaches have been adopted with success in the management of this disease in extending the time to the onset of the disease. Compared to other therapeutic leads used in conventional drug delivery nanoparticulate systems exhibit excellent penetrating power based on several factors and are most affecting in disease control. In the current study, isolongifolene ‑ loaded Chitosan nanoparticles have been formulated, synthesized and then characterized using Fourier transform infrared spectroscopy, X ‑ray Diffraction, Scanning Electron Microscopy, and Transmission Electron Microscopy. In addition, the characterized chitosan nanoformulation was tested in terms of bleeding time, plasma degradation, and also followed in simulated gastrointestinal media. Chitosan nanoparticles containing isolongifolene were shown to be stable in plasma and sustained the release profile. Therefore, chitosan loaded nanoparticles could be a suitable companion in cancer therapy to overcome multiple drug resistance of solid tumors.
Downloads
Metrics
References
Manimaran, D., et al. (2022). "Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment." Scientific Reports, 12(1), 1-13. [DOI: 10.1038/s41598-022-23386-4]
Chidambaram, M., et al. (2012). "Chitosan-based nanoparticle systems in drug delivery." Nanotechnology, 23(25), 455601.
Poonam, P., et al. (2020). "Chitosan and its derivatives in drug delivery: A comprehensive review." International Journal of Nanomedicine, 15, 6179-6201.
Rao, P. V., et al. (2018). "Phytochemical components of isolongifolene and their effects in oxidative stress." Phytotherapy Research, 32(2), 300-312.
Wang, L., et al. (2017). "Chitosan and its derivatives as drug carriers: A review." Carbohydrate Polymers, 157, 59-75.
Srinivasan, K. M., et al. (2018). "Chitosan nanoparticles for drug delivery and cancer therapy." Biomaterials Science, 6(6), 1537-1553.
Yang, J., et al. (2016). "Isolongifolene-loaded nanoparticles for controlled drug delivery: Synthesis and applications." Biomaterials, 107, 87-102.
Kadir, M. R., et al. (2016). "Anticancer activity of chitosan nanoparticles loaded with phytochemicals: A review." Nanomedicine: Nanotechnology, Biology, and Medicine, 12(3), 685-699.
Manchanda, R., et al. (2017). "Nanoparticle-based strategies for cancer therapy: The future of personalized medicine." Journal of Controlled Release, 243, 44-58.
Roy, I., et al. (2019). "Chitosan-based nanocarriers for anticancer drug delivery: Current strategies and future prospects." Advanced Drug Delivery Reviews, 139, 84-107.
Mishra, R. K., et al. (2021). "Synthesis and applications of chitosan nanoparticles in cancer therapy." Journal of Nanoscience and Nanotechnology, 21(1), 97-109.
Kumar, V., et al. (2018). "Chitosan-based nanoparticles: From preparation to application in cancer therapy." Asian Journal of Pharmaceutical Sciences, 13(4), 304-317.
Gan, L., et al. (2019). "Recent advances in chitosan-based nanoparticles for cancer therapy." Journal of Nanomaterials, 2019, Article 7190509.
Muzzarelli, R. A. A. (2010). "Chitosan as a pharmaceutical excipient: A review." Carbohydrate Polymers, 79(3), 299-309.
Garcia, M. A., et al. (2017). "Chitosan-based drug delivery systems for anticancer therapies: Recent advances." Nanomedicine, 12(16), 1997-2014.
Soliman, G. M., et al. (2019). "Chitosan nanoparticles for the treatment of multi-drug resistant cancers." Pharmacological Research, 148, 104442.
Ali, S., et al. (2017). "Chitosan nanoparticles for targeted drug delivery in cancer treatment." Journal of Drug Delivery Science and Technology, 41, 32-43.
Alvarado, P., et al. (2020). "Isolongifolene and its derivatives as therapeutic agents: A systematic review." Pharmacognosy Reviews, 14(27), 193-202.
Huang, J., et al. (2018). "Chitosan nanoparticles: A versatile drug delivery carrier for cancer therapy." Journal of Nanotechnology in Drug Delivery, 7(1), 23-34.
Zheng, X., et al. (2020). "Recent advances in the use of chitosan nanoparticles in cancer chemotherapy." Journal of Pharmaceutical Sciences, 109(9), 2587-2601.
Bhatt, S., et al. (2019). "Nanoparticle-based drug delivery systems for cancer treatment: A comprehensive review." Drug Delivery, 26(1), 162-181.
Bansal, S., et al. (2018). "Nanoparticles in cancer therapy: From bench to bedside." OncoTargets and Therapy, 11, 1085-1098.
Liu, H., et al. (2020). "Nanoformulations for targeted drug delivery in cancer treatment." Journal of Controlled Release, 323, 197-212.
Sen, S. G., et al. (2020). "Advances in cancer nanomedicine for targeted drug delivery." Biotechnology Advances, 42, 107569.
Singh, R., et al. (2019). "Nanoparticle-based targeted drug delivery in cancer therapy: A review." Therapeutic Delivery, 10(7), 443-460.
Cheng, Y., et al. (2018). "Chitosan-based nanocarriers for sustained drug delivery: A review." Materials Science and Engineering: C, 92, 26-40.
Karthik, S., et al. (2021). "Cancer-targeted drug delivery using nanocarriers: Recent advances." Materials Science and Engineering: C, 118, 111440.
Couvreur, P., et al. (2015). "Nanoparticles in cancer therapy and diagnosis." Nanomedicine: Nanotechnology, Biology, and Medicine, 11(3), 663-667.
De Jong, W. H., et al. (2008). "Toxicity of nanoparticles." Nanoscience and Nanotechnology, 8(7), 1649-1672.
Ciesielska, A., et al. (2017). "Cancer nanomedicine: A new era in oncology." Nanomaterials, 7(3), 65.
Pallavi, K., et al. (2020). "Chitosan nanoparticles for anticancer drug delivery: A review." International Journal of Nanomedicine, 15, 5271-5286.
Zhang, Y., et al. (2020). "Chitosan-based nanocarriers for drug delivery and cancer therapy." Journal of Nanoscience and Nanotechnology, 20(3), 1626-1643.
Akbarzadeh, A., et al. (2013). "Chitosan nanoparticles: Preparation, characterization, and applications." Nanoscale Research Letters, 8(1), 150.
Danhier, F., et al. (2012). "Chitosan nanoparticles: A review of preparation methods and applications in cancer treatment." Biomaterials, 33(18), 4537-4556.
Wang, L., et al. (2019). "Targeted drug delivery via chitosan nanoparticles for the treatment of breast cancer." International Journal of Nanomedicine, 14, 1271-1283.
Srivastava, S., et al. (2019). "Polymeric nanoparticles for the delivery of anticancer agents." Pharmacological Research, 139, 31-51.
Kharat, M. S., et al. (2021). "Nanoparticles in cancer therapy: Recent advancements." Biotechnology Reports, 30, e00598.
Mousavi, M., et al. (2019). "Chitosan nanoparticles for anticancer drug delivery: Current status and future directions." Nanomedicine: Nanotechnology, Biology, and Medicine, 18, 1-15.
Arora, S., et al. (2017). "Nanocarriers for cancer therapy: Current advances and future challenges." Journal of Drug Delivery Science and Technology, 41, 11-23.
Pardeike, J., et al. (2011). "Chitosan nanoparticles in drug delivery: Part II—Nanoparticles as carriers in drug delivery." Pharmaceutical Research, 28(5), 1284-1295.
Bhardwaj, R., et al. (2020). "Nanoparticles as therapeutic tools in cancer: A review." Molecular Pharmacology, 97(5), 611-625.
Patel, H., et al. (2021). "Chitosan nanoparticles: Synthesis, characterization, and applications in drug delivery and cancer therapy." Journal of Pharmaceutical Sciences, 110(1), 108-125.
Nam, J., et al. (2018). "Chitosan-based nanoparticles for cancer therapy: Targeting drug delivery systems." *Advanced Drug
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
